• Home
• News & Info
• Public Meetings
• FAQ's
• Contact Us

The Pharmacy and Therapeutics (P&T) Committee

The P&T Committee provides recommendations for the Medicaid Preferred Drug List (PDL). The Committee is composed of Physicians & Pharmacists who meet at least quarterly to consider PDL implementation. These meetings are generally scheduled on the third Thursday of every month at 7:00 A.M. in the Cannon Health Building at 288 N. 1460 W. in Salt Lake City, UT. The P&T Committee reserves the right to adjust the meeting schedule as necessary. Notices for exact meeting times and locations will be published in the Legal Notices sections of the Salt Lake Newspapers at least 24 hours in advance. You may also sign up to receive public notice for this meeting by email.

The meetings are open to the public.

Public Comments for the P&T Committee:

Public comment that responds to the materials presented by the Pharmacotherapy Outcomes Research Center at the Universityof Utah is most helpful. The foundation documents used for most reviews are prepared by the Oregon Evidence-Based Practice Center or the Pharmacotherapy Outcomes Research Center and are posted in advance on the P&T Committee website

Manufacturers are requested to submit any additional materials they would like reviewed as part of the process to:

Gary M. Oderda, Pharm.D., M.P.H
Professor and Director
Pharmacotherapy Outcomes Research Center
University of Utah College of Pharmacy
421 Wakara Way Suite 208
Salt Lake City, UT 84108

All materials must be clearly labeled that they are submitted for consideration as part of the State of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible) after the Oregon monograph was prepared, unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search.

Persons who wish to address the P&T Committee may contact Lisa Hunt by phone at 801-538-6317 or by emailat least 7 calendar days prior to the meeting. Comments from visitors, while welcome, may be limited due to time constraints

Listed below is a P&T Committee class review schedule. Criteria review documents can be found in the library located below the schedule:

January 2012: Ophthalmic Anti-Inflammatories
February 2012: Antivirals for HSV and Antivirals for Influenza

Listed below are meeting minutes, agendas, and reports regarding the P&T Committee. Clinical evidence documents prepared for the P&T Committee meetings will be kept on this website for 6 months.

Search the following files.    Note that '*' and '?' wildcards are supported.